SlideShare ist ein Scribd-Unternehmen logo
1 von 33
Downloaden Sie, um offline zu lesen
Laboratory Diagnosis for Common
Gastro-intestinal Infections
Dr Vincent CC Cheng
Department of Microbiology
Queen Mary Hospital
Diagnostic Clinical Microbiology
其 中 11 名 男 子, 進 食 過 燒 味 、 海 鮮
卷 、 石 斑 、 貴 妃 雞 及 鮮 鮑 蚌 等 食 品
St l lt S l ll t itidi
(2008-06-17 HKT 00:27)
Stool culture: Salmonella enteritidis
MacConkey XLD agar
Food borne infectious diseases
Water
(untreated)
Salmonella, shigella, cholera
H titi A/E C li i i /N lk i il litiHepatitis A/E. Caliciviruses/Norwalk virus, poilomyelitis
Giardia, cryptosporidium, cyclospora
Dairy
(unpasteurised)
Brucella, listeria, salmonella, shigella
(unpasteurised)
Raw or Enteric bacteria (salmonella, shigella, C. jejuni, etc)
undercooked
food
( g j j )
Helminths (ascaris, trichinella, taenia, etc)
Protozoa (amoebiasis, toxoplasma)
E t i fEnteric fever
Salmonella typhi & S. paratyphiyp p yp
Increasing fever over 1–2 weeks
Headache, abdominal pain
& cough
Rose spots
Fleeting lesions
2 - 3 mm pink-red macules
Rose spots
p
blanch with pressure
Blood culture
Antigenic formulae of some representative serotypes of
Salmonella (Kaulffman-White classification)
O-antigen group
A
Serotype name
Paratyphi A
O antigens and Vi
1,2,12
H antigens (I)
a
H antigens (II)
1,2
B Paratyphi B
Typhimurium
Agona
1,4,5,12
1,4,5,12
1,4,12
b
i
f,g,s
1,2
1,2
-
C1
Heidelberg
Choleraesuis
Paratyphi C
1,4,5,12
6,7
6 7 Vi
r
c
c
1,2
1,5
1 5Paratyphi C
Virchow
Infantis
6,7, Vi
6,7
6,7
c
r
r
1,5
1,2
1,5
C2-C3
D1
Newport
Hadar
Typhi
6,8
6,8
9,12, Vi
e,h
z10
d
1,2
e,n,x
-
Enteriditis
Dublin
1,9,12
1,9,12, Vi
g,m
g,p
-
-
Dysentery Low infectious doseDysentery
Intracellular multiplication
EHEC, Shigella
EIEC,
Campylobacter
Clin Microbiol Rev. 1998 Jan;11(1):142-201
Shigella species
Dept. of Microbiology, QMH
Campylobacter jejuni
CCDA
(charcoal-cefoperazon-deoxycholate agar)
Microaerophilic atmosphere:
5% O2, 10% CO2, 85% N2
42oC, 3 days
Dept. of Microbiology, QMH
Serotype of E. coli isolated from human diarrheal illness
O6:NM
O6:H16
O114:H21
O115:H21
O26:NM
O26:H11
O28ac:NM
O29:NM
O1:NM
O1:H1
O23:H7
O23:H16
O55:H10
O73:H34
O111:NM
O111:H2
O119:H5
O119:H6
O141:NM
O145:NM
ETEC EPEC EIEC EHEC
O6:H16
O8:H9
O11:H27
O15:H11
O115:H21
O126:H9
O128ac:H12
O128ac:H21
O26:H11
O55:NM
O55:H6
O55:H7
O29:NM
O112ac:NM
O115:NM
O124:NM
O1:H1
O1:H7
O2:H1
O2:H5
O23:H16
O25:NM
O26:NM
O26:H2
O73:H34
O75:H5
O82:H8
O84:H2
O111:H2
O111:H7
O111:H8
O111:H30
O119:H6
O120:H19
O121:NM
O121:H8
O145:NM
O145:H25
O146:NM
O146:H21
O29:NM
O25:NM
025:H42
O27:NM
O128ac:H27
O148:H28
O149:H4
O153:H45
O86:NM
O86:H2
O86:H34
O111ab:NM
O124:H7
O124:H30
O135:NM
O136:NM
O2:H6
O2:H7
O4:NM
O4:H10
O26:H8
O26:H11
O26:H32
O38:H21
O85:NM
O86:H110
O88:NM
O91:NM
O111:H34
O111:HNT
O112:H21
O113:H2
O121:H19
O125:NM
O125:H8
O126:NM
O153:H25
O157:NM
O157:H7
O163:H19O27:NM
O27:H7
O27:H20
O49:NM
O159:HNM
O159:H4
O159:H20
O111ab:H2
O111ab:H12
O111ab:H21
O143:NM
O144:NM
O152:NM
O4:H10
O5:NM
O5:H16
O6:NM
O39:H4
O45:NM
O45:H2
O91:NM
O91:H14
O100:H32
O101:H19
O113:H2
O113:H7
O113:H21
O113:H53
O126:H8
O126:H21
O128:NM
O163:H19
O165:NM
O165:H10
O165:H19
O63:H12
O78:H11
O78:H12
O85:H7
O166:H27
O167:H5
O169:H41
O114:NM
O114:H2
O119:H6
O128ab:H2
O164:NM
O167:NM
O6:H1
O6:H28
O18:NM
O18:H7
O48:H21
O50:NM
O50:H7
O52:H25
O103:H2
O103:H6
O104:NM
O104:H21
O114:H4
O114:H48
O115:H10
O115:H18
O128:H2
O128:H8
O128:H12
O128:H25
O165:H25
O166:H12
O166:H15
O142:H6
O158:H23
O22:H8
O22:H16
O55:NM
O55:H7
O105:H18
O110:H19
O117:H4
O118:H30
O132:NM
O133:H53
Serotype of E. coli O157:H7
Dept. of Microbiology, QMH
Treatment of bacterial dysentery
Ciprofloxacin
Dose (mg) po
Levofloxacin Norfloxacin
500 500 400Dose (mg) po
Cmax (µg/ml)
T1/2 (hr)
500
2.4
3 - 5
500
5.7
6 - 8
400
1.5
2 - 4
Cost (HK$) (3-d) 51.6 51.6 40.1
MIC90 (µg/ml)
E. Coli
Shigella spp
0.25
0.06
0.5
0.03
0.12
0.12Shigella spp
Campylobacter
0.06
64
0.03
32
0.12
NA
Fecal concentration: 100 1000 x serum concentrationFecal concentration: 100 - 1000 x serum concentration
Treatment of bacterial dysentery
Ciprofloxacin
Dose (mg) po
Azithromycin
500 500 10 mg/kgDose (mg) po
Cmax (µg/ml)
T1/2 (hr)
500
2.4
3 - 5
500
0.41
68
10 mg/kg
(Children)
Cost (HK$) (3-d) 51.6 78
MIC90 (µg/ml)
E. Coli
Shigella spp
0.25
0.06
< 4
< 4Shigella spp
Campylobacter
0.06
64
4
0.5
Tissue concentration: 10 100 x serum concentrationTissue concentration: 10 - 100 x serum concentration
Macrophage & neutrophil
Clinical features of traveler’s diarrheaC ca ea u es o a e e s d a ea
≥ 3 unformed stools within 24 hours with at least 1 of the following:
N iti bd i l iNausea, vomiting, abdominal pain
Fever, bloody stool
2 – 3 days after arrival
(90% within first 2 weeks)
Onset: Duration:
3 – 5 days
(90%)
> 2 weeks
(10%)
Duration:
0 1 2 >3
Travel
0 1 2 >3
Weeks post-travelHome
Approach to Vibrio (curved)Approach to
Cholera-like illness
Vibrio (curved)
TCBS
(thiosulphate citrate bile salts sucrose agar)
Vibrio cholerae Vibrio parahemolyticus
Dept. of Microbiology, QMH
Vibrio cholerae ? Serotype
Agglutination test: O1 & O139, Non O1
Dept. of Microbiology, QMH
The first imported case of cholera inp
2008
From Philippine
Notification data (DH)
2003: 7003
2004: 5
2005: 5
2006: 1
2007: 3
2008: 1 (till 8 Apr 08)
Oriental daily 8 Apr 2008
Cholera stool Treatment ofCholera stool
500 - 1000 ml / hr
Treatment of
watery diarrhea
Rehydration
Rehydration
Rehydration
Rehydration
Rehydration
Rehydration
Lancet. 2004 Jan 17;363(9404):223-33
Approach to Cholera-like diarrhea
RotavirusRotavirus
(Age of extremities)
Norovirus virus
Positive
Control
Negative
Control
Patient
1 2
113 bp
RT-PCR for ORF1 of Norwalk virus
Dept. of Microbiology, QMH
Minimum infective dose of viral gastroenteritis
1011 / g of stool
Rotavirus
10 viral particles
3 x 107 / vomiting
Norovirus
10 - 100 viral particles
Entamobea histolyticaEntamobea histolytica
By Trichrome stain
10µm
Dept. of Microbiology, QMH
Giardia intestinalis
By Trichrome stain
10um
Dept. of Microbiology, QMH
Before inoculation
After inoculationAfter inoculation
Laribacter hongkongensis gen. nov. sp. nov.Laribacter hongkongensis gen. nov. sp. nov.
M/54 Oxidase +
Alcoholic cirrhosis & portal HT
Empyema thoracis & bacteraemia
Catalase +
Urease +
Arginine dihydrolase +
S-shaped Gram-ve bacillus
Growth
g y
Nitrate reduction +
25°C - 42°C
0-2% NaCl
MacConkey agar
Facultative anaerobic
J Clin Microbiol. 2001 Dec;39(12):4227-32.
Cefoperazone (32 μg/ml) MacConkey agar:
selective medium for Laribacter hongkongensisselective medium for Laribacter hongkongensis
BA, aerobic
48 h
CMA, aerobic
48 h48 h 48 h
CCDA, aerobic
48 h
CCDA, microaerophilic
48 h
Risk factors for gastroenteritis associated with
L ib t h k iLaribacter hongkongensis
Characteristics Patients with L Controls P valueCharacteristics Patients with L.
hongkongensis
GE (n=17)
Controls
without
GE (n=34)
P value
Recent travel histories 10 2 <0 001Recent travel histories 10 2 <0.001
Consumption of fish within 3
days prior to onset of
16 19 <0.01
y p
diarrhoea/interview
Consumption of minced 5 1 <0 05Consumption of minced
freshwater fish meat within 3
days prior to onset of
diarrhoea/interview
5 1 <0.05
Lancet. 2004 Jun 12;363(9425):1941-7.

Weitere ähnliche Inhalte

Was ist angesagt?

Enterobacteriaceae
EnterobacteriaceaeEnterobacteriaceae
Enterobacteriaceae
DrAbbasHayat
 
Lecture 1 Staphylococcus aureus
Lecture 1 Staphylococcus aureusLecture 1 Staphylococcus aureus
Lecture 1 Staphylococcus aureus
-
 
Enterobacteriaceae
EnterobacteriaceaeEnterobacteriaceae
Enterobacteriaceae
Gopi sankar
 
E coli lectur revised alpana
E coli lectur revised alpanaE coli lectur revised alpana
E coli lectur revised alpana
Bruno Mmassy
 
Production of African Cassava Mosaic Virus (ACMV) Specific Polyclonal Antibod...
Production of African Cassava Mosaic Virus (ACMV) Specific Polyclonal Antibod...Production of African Cassava Mosaic Virus (ACMV) Specific Polyclonal Antibod...
Production of African Cassava Mosaic Virus (ACMV) Specific Polyclonal Antibod...
iosrjce
 
Spread of antibiotic resistant bacteria-Libya
Spread of antibiotic resistant bacteria-LibyaSpread of antibiotic resistant bacteria-Libya
Spread of antibiotic resistant bacteria-Libya
-
 
Final Presentation Powerpoint (1)
Final Presentation Powerpoint (1)Final Presentation Powerpoint (1)
Final Presentation Powerpoint (1)
Sarah Weber
 
Classic and new emerging enteric pathogens-Tripoli-Libya
Classic and new emerging enteric pathogens-Tripoli-LibyaClassic and new emerging enteric pathogens-Tripoli-Libya
Classic and new emerging enteric pathogens-Tripoli-Libya
-
 

Was ist angesagt? (19)

Enterobacteriaceae
EnterobacteriaceaeEnterobacteriaceae
Enterobacteriaceae
 
Lecture 1 Staphylococcus aureus
Lecture 1 Staphylococcus aureusLecture 1 Staphylococcus aureus
Lecture 1 Staphylococcus aureus
 
Detection and Subtype Identification of Blastocystis Isolates from Wastewater...
Detection and Subtype Identification of Blastocystis Isolates from Wastewater...Detection and Subtype Identification of Blastocystis Isolates from Wastewater...
Detection and Subtype Identification of Blastocystis Isolates from Wastewater...
 
Medical Microbiology Laboratory (Vibrio spp.)
Medical Microbiology Laboratory (Vibrio spp.)Medical Microbiology Laboratory (Vibrio spp.)
Medical Microbiology Laboratory (Vibrio spp.)
 
presentation on E.coli
presentation on E.colipresentation on E.coli
presentation on E.coli
 
The occurrence of AmpC β-lactamase and ESBL producing Gram-negative bacteria ...
The occurrence of AmpC β-lactamase and ESBL producing Gram-negative bacteria ...The occurrence of AmpC β-lactamase and ESBL producing Gram-negative bacteria ...
The occurrence of AmpC β-lactamase and ESBL producing Gram-negative bacteria ...
 
Enterobacteriaceae
EnterobacteriaceaeEnterobacteriaceae
Enterobacteriaceae
 
Amparo Latorre - Simposio Microbiología: Transmisión
Amparo Latorre - Simposio Microbiología: TransmisiónAmparo Latorre - Simposio Microbiología: Transmisión
Amparo Latorre - Simposio Microbiología: Transmisión
 
revision 2014
  revision  2014  revision  2014
revision 2014
 
5. diarheal diseases of E.coli Dr. Mahadi H Abdallah
5. diarheal diseases of E.coli  Dr. Mahadi  H  Abdallah5. diarheal diseases of E.coli  Dr. Mahadi  H  Abdallah
5. diarheal diseases of E.coli Dr. Mahadi H Abdallah
 
Microbiology academic papers and microbiology project topics
Microbiology  academic papers and microbiology project topicsMicrobiology  academic papers and microbiology project topics
Microbiology academic papers and microbiology project topics
 
Research Proposal
Research ProposalResearch Proposal
Research Proposal
 
E coli lectur revised alpana
E coli lectur revised alpanaE coli lectur revised alpana
E coli lectur revised alpana
 
Production of African Cassava Mosaic Virus (ACMV) Specific Polyclonal Antibod...
Production of African Cassava Mosaic Virus (ACMV) Specific Polyclonal Antibod...Production of African Cassava Mosaic Virus (ACMV) Specific Polyclonal Antibod...
Production of African Cassava Mosaic Virus (ACMV) Specific Polyclonal Antibod...
 
Brucella and brucellosis
Brucella and brucellosisBrucella and brucellosis
Brucella and brucellosis
 
Spread of antibiotic resistant bacteria-Libya
Spread of antibiotic resistant bacteria-LibyaSpread of antibiotic resistant bacteria-Libya
Spread of antibiotic resistant bacteria-Libya
 
Final Presentation Powerpoint (1)
Final Presentation Powerpoint (1)Final Presentation Powerpoint (1)
Final Presentation Powerpoint (1)
 
Classic and new emerging enteric pathogens-Tripoli-Libya
Classic and new emerging enteric pathogens-Tripoli-LibyaClassic and new emerging enteric pathogens-Tripoli-Libya
Classic and new emerging enteric pathogens-Tripoli-Libya
 
E coli haveen
E coli haveenE coli haveen
E coli haveen
 

Andere mochten auch

UTI- Urinary Tract Infection
UTI- Urinary Tract InfectionUTI- Urinary Tract Infection
UTI- Urinary Tract Infection
Soumar Dutta
 
Respiratory Diseases
Respiratory DiseasesRespiratory Diseases
Respiratory Diseases
shas595
 

Andere mochten auch (14)

Short presentation version cns infections Lecture
Short presentation version cns infections LectureShort presentation version cns infections Lecture
Short presentation version cns infections Lecture
 
Lower respiratory tract infection
Lower respiratory tract infectionLower respiratory tract infection
Lower respiratory tract infection
 
UTI- Urinary Tract Infection
UTI- Urinary Tract InfectionUTI- Urinary Tract Infection
UTI- Urinary Tract Infection
 
Respiratory Diseases
Respiratory DiseasesRespiratory Diseases
Respiratory Diseases
 
Fungal infection
Fungal infection Fungal infection
Fungal infection
 
Systemic Mycoses
Systemic MycosesSystemic Mycoses
Systemic Mycoses
 
Laboratory diagnosis of viral infection
Laboratory diagnosis of viral infectionLaboratory diagnosis of viral infection
Laboratory diagnosis of viral infection
 
4 bacterial infection and pathogenesis
4  bacterial infection and pathogenesis4  bacterial infection and pathogenesis
4 bacterial infection and pathogenesis
 
Osteomyelitis
OsteomyelitisOsteomyelitis
Osteomyelitis
 
Skin and Soft tissue infections
Skin and Soft  tissue  infectionsSkin and Soft  tissue  infections
Skin and Soft tissue infections
 
Osteomyelitis
OsteomyelitisOsteomyelitis
Osteomyelitis
 
Sepsis And Septic Shock
Sepsis And Septic ShockSepsis And Septic Shock
Sepsis And Septic Shock
 
The Top Skills That Can Get You Hired in 2017
The Top Skills That Can Get You Hired in 2017The Top Skills That Can Get You Hired in 2017
The Top Skills That Can Get You Hired in 2017
 
LinkedIn SlideShare: Knowledge, Well-Presented
LinkedIn SlideShare: Knowledge, Well-PresentedLinkedIn SlideShare: Knowledge, Well-Presented
LinkedIn SlideShare: Knowledge, Well-Presented
 

Ähnlich wie Labdx g iinfection_print

Enteric pathogens-Tripoli-Libya
Enteric pathogens-Tripoli-LibyaEnteric pathogens-Tripoli-Libya
Enteric pathogens-Tripoli-Libya
-
 
Liver Enzymes Assay and Haematological Parameters of Bacteria Infected Guinea...
Liver Enzymes Assay and Haematological Parameters of Bacteria Infected Guinea...Liver Enzymes Assay and Haematological Parameters of Bacteria Infected Guinea...
Liver Enzymes Assay and Haematological Parameters of Bacteria Infected Guinea...
SSR Institute of International Journal of Life Sciences
 
The prevalence of Escherichia coli Causing Urinary Tract Infections in Aminu ...
The prevalence of Escherichia coli Causing Urinary Tract Infections in Aminu ...The prevalence of Escherichia coli Causing Urinary Tract Infections in Aminu ...
The prevalence of Escherichia coli Causing Urinary Tract Infections in Aminu ...
Premier Publishers
 

Ähnlich wie Labdx g iinfection_print (20)

Medical Microbiology Laboratory (Aeromonas, Helicobacter and Campylobacter spp.)
Medical Microbiology Laboratory (Aeromonas, Helicobacter and Campylobacter spp.)Medical Microbiology Laboratory (Aeromonas, Helicobacter and Campylobacter spp.)
Medical Microbiology Laboratory (Aeromonas, Helicobacter and Campylobacter spp.)
 
Identification of vibrio cholerae pathogenicity
Identification of vibrio cholerae pathogenicityIdentification of vibrio cholerae pathogenicity
Identification of vibrio cholerae pathogenicity
 
Journal of Bacteriology and Mycology
Journal of Bacteriology and MycologyJournal of Bacteriology and Mycology
Journal of Bacteriology and Mycology
 
Enteric pathogens-Tripoli-Libya
Enteric pathogens-Tripoli-LibyaEnteric pathogens-Tripoli-Libya
Enteric pathogens-Tripoli-Libya
 
Enterobacteria Microbiology
Enterobacteria MicrobiologyEnterobacteria Microbiology
Enterobacteria Microbiology
 
Liver Enzymes Assay and Haematological Parameters of Bacteria Infected Guinea...
Liver Enzymes Assay and Haematological Parameters of Bacteria Infected Guinea...Liver Enzymes Assay and Haematological Parameters of Bacteria Infected Guinea...
Liver Enzymes Assay and Haematological Parameters of Bacteria Infected Guinea...
 
Investigation of a community outbreak of typhoid fever
Investigation of a community outbreak of typhoid feverInvestigation of a community outbreak of typhoid fever
Investigation of a community outbreak of typhoid fever
 
Typhoid Fever: Clinical Manifestations, Diagnosis, Treatment & Prevention
Typhoid Fever: Clinical Manifestations, Diagnosis, Treatment & PreventionTyphoid Fever: Clinical Manifestations, Diagnosis, Treatment & Prevention
Typhoid Fever: Clinical Manifestations, Diagnosis, Treatment & Prevention
 
Isolation, identification and characterization of urinary tract infectious ba...
Isolation, identification and characterization of urinary tract infectious ba...Isolation, identification and characterization of urinary tract infectious ba...
Isolation, identification and characterization of urinary tract infectious ba...
 
Opportunistic Protozoans - Microbiology
Opportunistic Protozoans - MicrobiologyOpportunistic Protozoans - Microbiology
Opportunistic Protozoans - Microbiology
 
Assessment of the immune status of nile tilapia (oreochromis niloticus) exper...
Assessment of the immune status of nile tilapia (oreochromis niloticus) exper...Assessment of the immune status of nile tilapia (oreochromis niloticus) exper...
Assessment of the immune status of nile tilapia (oreochromis niloticus) exper...
 
Vaccination in Finfishes
Vaccination in FinfishesVaccination in Finfishes
Vaccination in Finfishes
 
Presentation.pptx
Presentation.pptxPresentation.pptx
Presentation.pptx
 
Probiotics 2016
Probiotics 2016Probiotics 2016
Probiotics 2016
 
Fungal Contamination
Fungal ContaminationFungal Contamination
Fungal Contamination
 
Cholera
CholeraCholera
Cholera
 
Antitumor and immunostimulating effects of Anoectochilus formosanus Hayata
Antitumor and immunostimulating effects of Anoectochilus formosanus HayataAntitumor and immunostimulating effects of Anoectochilus formosanus Hayata
Antitumor and immunostimulating effects of Anoectochilus formosanus Hayata
 
Antitumor and immunostimulating effects of Anoectochilus formosanus Hayata
Antitumor and immunostimulating effects of Anoectochilus formosanus HayataAntitumor and immunostimulating effects of Anoectochilus formosanus Hayata
Antitumor and immunostimulating effects of Anoectochilus formosanus Hayata
 
The prevalence of Escherichia coli Causing Urinary Tract Infections in Aminu ...
The prevalence of Escherichia coli Causing Urinary Tract Infections in Aminu ...The prevalence of Escherichia coli Causing Urinary Tract Infections in Aminu ...
The prevalence of Escherichia coli Causing Urinary Tract Infections in Aminu ...
 
Uti
UtiUti
Uti
 

Labdx g iinfection_print

  • 1. Laboratory Diagnosis for Common Gastro-intestinal Infections Dr Vincent CC Cheng Department of Microbiology Queen Mary Hospital
  • 3. 其 中 11 名 男 子, 進 食 過 燒 味 、 海 鮮 卷 、 石 斑 、 貴 妃 雞 及 鮮 鮑 蚌 等 食 品 St l lt S l ll t itidi (2008-06-17 HKT 00:27) Stool culture: Salmonella enteritidis MacConkey XLD agar
  • 4. Food borne infectious diseases Water (untreated) Salmonella, shigella, cholera H titi A/E C li i i /N lk i il litiHepatitis A/E. Caliciviruses/Norwalk virus, poilomyelitis Giardia, cryptosporidium, cyclospora Dairy (unpasteurised) Brucella, listeria, salmonella, shigella (unpasteurised) Raw or Enteric bacteria (salmonella, shigella, C. jejuni, etc) undercooked food ( g j j ) Helminths (ascaris, trichinella, taenia, etc) Protozoa (amoebiasis, toxoplasma)
  • 5. E t i fEnteric fever Salmonella typhi & S. paratyphiyp p yp Increasing fever over 1–2 weeks Headache, abdominal pain & cough Rose spots Fleeting lesions 2 - 3 mm pink-red macules Rose spots p blanch with pressure
  • 7.
  • 8.
  • 9.
  • 10.
  • 11. Antigenic formulae of some representative serotypes of Salmonella (Kaulffman-White classification) O-antigen group A Serotype name Paratyphi A O antigens and Vi 1,2,12 H antigens (I) a H antigens (II) 1,2 B Paratyphi B Typhimurium Agona 1,4,5,12 1,4,5,12 1,4,12 b i f,g,s 1,2 1,2 - C1 Heidelberg Choleraesuis Paratyphi C 1,4,5,12 6,7 6 7 Vi r c c 1,2 1,5 1 5Paratyphi C Virchow Infantis 6,7, Vi 6,7 6,7 c r r 1,5 1,2 1,5 C2-C3 D1 Newport Hadar Typhi 6,8 6,8 9,12, Vi e,h z10 d 1,2 e,n,x - Enteriditis Dublin 1,9,12 1,9,12, Vi g,m g,p - -
  • 12. Dysentery Low infectious doseDysentery Intracellular multiplication EHEC, Shigella EIEC, Campylobacter Clin Microbiol Rev. 1998 Jan;11(1):142-201
  • 13. Shigella species Dept. of Microbiology, QMH
  • 16. Serotype of E. coli isolated from human diarrheal illness O6:NM O6:H16 O114:H21 O115:H21 O26:NM O26:H11 O28ac:NM O29:NM O1:NM O1:H1 O23:H7 O23:H16 O55:H10 O73:H34 O111:NM O111:H2 O119:H5 O119:H6 O141:NM O145:NM ETEC EPEC EIEC EHEC O6:H16 O8:H9 O11:H27 O15:H11 O115:H21 O126:H9 O128ac:H12 O128ac:H21 O26:H11 O55:NM O55:H6 O55:H7 O29:NM O112ac:NM O115:NM O124:NM O1:H1 O1:H7 O2:H1 O2:H5 O23:H16 O25:NM O26:NM O26:H2 O73:H34 O75:H5 O82:H8 O84:H2 O111:H2 O111:H7 O111:H8 O111:H30 O119:H6 O120:H19 O121:NM O121:H8 O145:NM O145:H25 O146:NM O146:H21 O29:NM O25:NM 025:H42 O27:NM O128ac:H27 O148:H28 O149:H4 O153:H45 O86:NM O86:H2 O86:H34 O111ab:NM O124:H7 O124:H30 O135:NM O136:NM O2:H6 O2:H7 O4:NM O4:H10 O26:H8 O26:H11 O26:H32 O38:H21 O85:NM O86:H110 O88:NM O91:NM O111:H34 O111:HNT O112:H21 O113:H2 O121:H19 O125:NM O125:H8 O126:NM O153:H25 O157:NM O157:H7 O163:H19O27:NM O27:H7 O27:H20 O49:NM O159:HNM O159:H4 O159:H20 O111ab:H2 O111ab:H12 O111ab:H21 O143:NM O144:NM O152:NM O4:H10 O5:NM O5:H16 O6:NM O39:H4 O45:NM O45:H2 O91:NM O91:H14 O100:H32 O101:H19 O113:H2 O113:H7 O113:H21 O113:H53 O126:H8 O126:H21 O128:NM O163:H19 O165:NM O165:H10 O165:H19 O63:H12 O78:H11 O78:H12 O85:H7 O166:H27 O167:H5 O169:H41 O114:NM O114:H2 O119:H6 O128ab:H2 O164:NM O167:NM O6:H1 O6:H28 O18:NM O18:H7 O48:H21 O50:NM O50:H7 O52:H25 O103:H2 O103:H6 O104:NM O104:H21 O114:H4 O114:H48 O115:H10 O115:H18 O128:H2 O128:H8 O128:H12 O128:H25 O165:H25 O166:H12 O166:H15 O142:H6 O158:H23 O22:H8 O22:H16 O55:NM O55:H7 O105:H18 O110:H19 O117:H4 O118:H30 O132:NM O133:H53
  • 17. Serotype of E. coli O157:H7 Dept. of Microbiology, QMH
  • 18. Treatment of bacterial dysentery Ciprofloxacin Dose (mg) po Levofloxacin Norfloxacin 500 500 400Dose (mg) po Cmax (µg/ml) T1/2 (hr) 500 2.4 3 - 5 500 5.7 6 - 8 400 1.5 2 - 4 Cost (HK$) (3-d) 51.6 51.6 40.1 MIC90 (µg/ml) E. Coli Shigella spp 0.25 0.06 0.5 0.03 0.12 0.12Shigella spp Campylobacter 0.06 64 0.03 32 0.12 NA Fecal concentration: 100 1000 x serum concentrationFecal concentration: 100 - 1000 x serum concentration
  • 19. Treatment of bacterial dysentery Ciprofloxacin Dose (mg) po Azithromycin 500 500 10 mg/kgDose (mg) po Cmax (µg/ml) T1/2 (hr) 500 2.4 3 - 5 500 0.41 68 10 mg/kg (Children) Cost (HK$) (3-d) 51.6 78 MIC90 (µg/ml) E. Coli Shigella spp 0.25 0.06 < 4 < 4Shigella spp Campylobacter 0.06 64 4 0.5 Tissue concentration: 10 100 x serum concentrationTissue concentration: 10 - 100 x serum concentration Macrophage & neutrophil
  • 20. Clinical features of traveler’s diarrheaC ca ea u es o a e e s d a ea ≥ 3 unformed stools within 24 hours with at least 1 of the following: N iti bd i l iNausea, vomiting, abdominal pain Fever, bloody stool 2 – 3 days after arrival (90% within first 2 weeks) Onset: Duration: 3 – 5 days (90%) > 2 weeks (10%) Duration: 0 1 2 >3 Travel 0 1 2 >3 Weeks post-travelHome
  • 21. Approach to Vibrio (curved)Approach to Cholera-like illness Vibrio (curved) TCBS (thiosulphate citrate bile salts sucrose agar) Vibrio cholerae Vibrio parahemolyticus Dept. of Microbiology, QMH
  • 22. Vibrio cholerae ? Serotype Agglutination test: O1 & O139, Non O1 Dept. of Microbiology, QMH
  • 23. The first imported case of cholera inp 2008 From Philippine Notification data (DH) 2003: 7003 2004: 5 2005: 5 2006: 1 2007: 3 2008: 1 (till 8 Apr 08) Oriental daily 8 Apr 2008
  • 24. Cholera stool Treatment ofCholera stool 500 - 1000 ml / hr Treatment of watery diarrhea Rehydration Rehydration Rehydration Rehydration Rehydration Rehydration Lancet. 2004 Jan 17;363(9404):223-33
  • 25. Approach to Cholera-like diarrhea RotavirusRotavirus (Age of extremities)
  • 26. Norovirus virus Positive Control Negative Control Patient 1 2 113 bp RT-PCR for ORF1 of Norwalk virus Dept. of Microbiology, QMH
  • 27. Minimum infective dose of viral gastroenteritis 1011 / g of stool Rotavirus 10 viral particles 3 x 107 / vomiting Norovirus 10 - 100 viral particles
  • 28. Entamobea histolyticaEntamobea histolytica By Trichrome stain 10µm Dept. of Microbiology, QMH
  • 29. Giardia intestinalis By Trichrome stain 10um Dept. of Microbiology, QMH
  • 31. Laribacter hongkongensis gen. nov. sp. nov.Laribacter hongkongensis gen. nov. sp. nov. M/54 Oxidase + Alcoholic cirrhosis & portal HT Empyema thoracis & bacteraemia Catalase + Urease + Arginine dihydrolase + S-shaped Gram-ve bacillus Growth g y Nitrate reduction + 25°C - 42°C 0-2% NaCl MacConkey agar Facultative anaerobic J Clin Microbiol. 2001 Dec;39(12):4227-32.
  • 32. Cefoperazone (32 μg/ml) MacConkey agar: selective medium for Laribacter hongkongensisselective medium for Laribacter hongkongensis BA, aerobic 48 h CMA, aerobic 48 h48 h 48 h CCDA, aerobic 48 h CCDA, microaerophilic 48 h
  • 33. Risk factors for gastroenteritis associated with L ib t h k iLaribacter hongkongensis Characteristics Patients with L Controls P valueCharacteristics Patients with L. hongkongensis GE (n=17) Controls without GE (n=34) P value Recent travel histories 10 2 <0 001Recent travel histories 10 2 <0.001 Consumption of fish within 3 days prior to onset of 16 19 <0.01 y p diarrhoea/interview Consumption of minced 5 1 <0 05Consumption of minced freshwater fish meat within 3 days prior to onset of diarrhoea/interview 5 1 <0.05 Lancet. 2004 Jun 12;363(9425):1941-7.